Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

A woman with lupus had rare severe symptoms but improved with treatment.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Fetal skin has unique immune cells different from adult skin.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

False high testosterone levels were corrected using a more accurate test.

Inflammation damages sweat ducts, causing sweat gland injury.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Women with PCOS are more likely to have thyroid antibodies than those without.

The condition is likely inherited in an autosomal-dominant pattern.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.